Follow The Filings

BDSX Biodesix

Biodesix earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.75 — —
Rev $27.6M — —

Insider trades

Open-market buys and sales by BDSX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BDSX insider trades
  • $3.1M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Jack W Schuler 10% owner
    Buy
    $367K 15,000 shares at $24.47 +2.8% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  2. Jack W Schuler 10% owner
    Buy
    $666K 27,600 shares at $24.13 +5.4% to stake
    Traded Aug 10–11 Filed Aug 12
    ↗
  3. Jack W Schuler 10% owner
    Buy
    $1.2M 100,000 shares at $11.81 +6.8% to stake
    Traded Jan 23–26 Filed Jan 27
    ↗
  4. Jack W Schuler 10% owner
    Buy
    $904K 82,465 shares at $10.96 +6% to stake
    Traded Jan 22 Filed Jan 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 24 option exercises and 20 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
424B3 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf